Ocrelizumab versus Placebo in Primary Progressive Multiple SclerosisNEJM 376:209-220,280, Montalban, X.,et al, 2017
Primary Leptomeningeal LymphomaNeurol 81:1690-1696, Taylor, J.W.,et al, 2013